Breaking News Instant updates and real-time market news.

SNAK

Inventure Foods

$3.35

-0.04 (-1.18%)

, SENS

Senseonics

$3.00

0.01 (0.33%)

17:48
09/12/17
09/12
17:48
09/12/17
17:48

On The Fly: After Hours Movers

HIGHER: Inventure Foods (SNAK), up 26.9% after it agreed to sell its frozen business to Oregon Potato Company for $50M... Senseonics (SENS), up 11.7% after it announced CE Mark approval for its Eversense XL CGM system... Nordstrom (JWN), up 9.4% after CNBC reported that the Nordstrom family is close to a deal to choose Leonard Green to help fund a buyout of the department store chain... Zafgen (ZFGN), up 4.7% after the company initiated a Phase 2 trial for ZGN-1061 in patients with type 2 diabetes... Centene (CNC), up 3.4% after it agreed to acquire substantially all assets of Fidelis Care for $3.75B... Terex (TEX), up 2.1% after Marcato's Mick McGuire said that the company may have "geometric" earnings growth ahead... Micron (MU), up 1.7% after the stock was upgraded to Buy from Neutral at Goldman Sachs. DOWN AFTER EARNINGS: A-Mark Precious Metals (AMRK), down 14.4%... Radiant Logistics (RLGT), down 6.4%. ALSO LOWER: Whiting Petroleum (WLL), down 3.6% after the stock was downgraded to Underweight from Equal Weight at Morgan Stanley... Celldex (CLDX), down 3% after chief medical officer Thomas Davis resigned from the company... AGNC Investment (AGNC), down 3.3% after it filed to sell 24.5M shares of common stock... ON Semiconductor (ON), down 1.4% after the stock was downgraded to Neutral from Buy at Goldman Sachs.

SNAK

Inventure Foods

$3.35

-0.04 (-1.18%)

SENS

Senseonics

$3.00

0.01 (0.33%)

JWN

Nordstrom

$45.05

0.33 (0.74%)

ZFGN

Zafgen

CNC

Centene

$90.88

0.34 (0.38%)

TEX

Terex

$41.73

1.68 (4.19%)

MU

Micron

$34.29

0.85 (2.54%)

AMRK

A-Mark Precious Metals

$18.82

0.79 (4.38%)

RLGT

Radiant Logistics

$5.45

0.25 (4.81%)

WLL

Whiting Petroleum

$4.44

0.33 (8.03%)

CLDX

Celldex

$2.66

-0.03 (-1.12%)

AGNC

AGNC Investment

$21.50

-0.01 (-0.05%)

ON

ON Semiconductor

$16.99

-0.13 (-0.76%)

  • 12

    Sep

  • 12

    Sep

  • 12

    Sep

  • 12

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 02

    Oct

  • 24

    Oct

  • 13

    Sep

SNAK Inventure Foods
$3.35

-0.04 (-1.18%)

11/03/16
ROTH
11/03/16
NO CHANGE
Target $10.5
ROTH
Buy
Roth Capital remains a buyer of Inventure Foods
Roth Capital analyst Anton Brenner notes that an earnings full recovery may take a bit longer than he had anticipated, although the analyst believes the company to be "solidly" profitable in 2017. Brenner continues to anticipate historically peak income by 2018, and says that while the large debt position is a headwind, a strategic review underway suggests an acquisition is possible. He reiterates a Buy rating and $10.50 price target on the shares.
01/13/17
DADA
01/13/17
DOWNGRADE
DADA
Neutral
Inventure Foods downgraded to Neutral from Buy at DA Davidson
01/13/17
DADA
01/13/17
DOWNGRADE
Target $8
DADA
Neutral
Inventure Foods downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Eric Gottlieb downgraded Inventure Foods to Neutral citing a "diminished outlook" on the sale of the entire business as well as an increased possibility for an equity offering or rights offering. The company, currently exploring strategic options, more than likely won't exist in its current form beyond June and many options are on the table, Gottlieb tells investors in a research note. He cut his price target for the shares to $8 from $10.
SENS Senseonics
$3.00

0.01 (0.33%)

09/27/16
RILY
09/27/16
INITIATION
Target $5.5
RILY
Buy
Senseonics initiated with a Buy at B. Riley
B. Riley analyst Greg Chodaczek started Senseonics with a Buy rating and $5.50 price target. Eversense is the only long-term, implantable continuous glucose monitoring system, Chodaczek tells investors in a research note.
12/19/16
12/19/16
UPGRADE
Target $84

Outperform
Dexcom upgraded to Outperform at Oppenheimer
As previously reported, Oppenheimer analyst Steven Lichtman upgraded Dexcom (DXCM) to Outperform from Perform, with an $84 price target, given valuation reflecting competitive concerns and big long-term opportunities in place. While new competition in the U.S. is expected from Medtronic (MDT) and likely Abbott (ABT) and Senseonics (SENS) in 2017, the analyst believes the CGM market remains underpenetrated in Type 1 patients, a dosing claim is expected early 2017, international reimbursement should be a growing tailwind and 2018 brings new growth drivers with expected launch of Dexcom's next-generation G6 and potential Medicare expansion.
06/06/17
LEER
06/06/17
NO CHANGE
Target $6
LEER
Outperform
Senseonics share offering removes overhang, says Leerink
Leerink analyst Danielle Antalffy views Senseonics' recent $41M share offering as a "financially sound move" that removes an overhang. The company's balance sheet is now shored up ahead of the U.S. launch, Antalffy tells investors in a research note. Senseonics' cash position should be sufficient to fund its operations at least through mid-2018, the analyst adds. She views the current valuation levels as an attractive entry point and reiterates an Outperform rating on the shares with a $6 price target.
JWN Nordstrom
$45.05

0.33 (0.74%)

07/14/17
JPMS
07/14/17
NO CHANGE
JPMS
Underweight
JPMorgan keeps Underweight on Nordstrom after management meetings
JPMorgan analyst Matthew Boss keeps an Underweight rating on Nordstrom (JWN) after meeting management at the company's headquarters. Management would not comment on their evaluation of strategic alternatives and the meeting was reshuffled to exclude members of the Nordstrom family while incoming CFO Anne Bramman attended but did not actively participate, Boss tells investors in a research note. The analyst views the company's EBITDA roadmap as "increasingly uncertain" with a greater emphasis on fashion to differentiate mix versus Amazon.com (AMZN) and rising costs of customer acquisition. He believes the retailer's fundamental multi-year risk profile is elevated.
06/21/17
GDHS
06/21/17
NO CHANGE
GDHS
Nike-Amazon pact yet another department store headwind, says Gordon Haskett
Gordon Haskett analyst noted the reports of Nike (NKE) nearing a deal to sell directly on Amazon (AMZN), which he said wouldn't impact trends overnight but would represent another headwind for department stores, particularly J.C. Penney (JCP) and Kohl's (KSS), where the brand has a larger penetration than at Macy's (M) and Nordstrom (JWN). He keeps an Accumulate rating on Nordstrom, a Hold rating on Macy's and Reduce rating on both J.C. Penney and Kohl's.
06/14/17
CLVD
06/14/17
NO CHANGE
CLVD
Nordstrom Q2 comps likely trending below consensus at Cleveland Research
06/09/17
06/09/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Snap (SNAP) downgraded to Neutral from Buy at Citi with analyst Mark May saying a slower than expected roll-out of new platforms and channels like self-serve is slowing down the pace of monetization growth. 2. Domino's Pizza (DPZ) downgraded to Neutral from Buy at Longbow with analyst Alton Stump saying his checks indicate second quarter domestic franchised comparables are up 6.25%-6.75%, versus consensus of 7.4%, and recommends investors take a pause on putting new money to work given recent share strength. 3. Nordstrom (JWN) downgraded to Neutral from Buy at Guggenheim with analyst Michael Binetti saying he does not see much further upside potential, even in a leveraged buyout scenario. The analyst believes a going private buyer could only pay $46 per share to generate a 10% internal rate of return. 4. Cantel Medical (CMD) downgraded to Hold from Buy at Benchmark with analyst Raymond Myers saying that he is increasingly concerned that its comparisons become tougher in the next two quarters. 5. Endo (ENDP) downgraded to Hold following Opana ER removal from market at Stifel with analyst Annabel Samimy saying Endo's recovery "just got harder" following the FDA's request for the company to voluntarily remove Opana ER from the market. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ZFGN Zafgen

01/06/17
01/06/17
UPGRADE
Target $8

Outperform
Zafgen upgraded to Outperform ahead of weight loss drug data at JMP Securities
As previously reported, JMP Securities analyst Jason Butler upgraded Zafgen to Outperform from Market Perform and set an $8 price target on the shares, as he believes the Phase 1 results for the company's second-generation MetAP2 inhibitor, ZGN-1061, will likely demonstrate proof-of-concept weight loss efficacy with a favorable safety profile.
04/20/17
ROTH
04/20/17
INITIATION
Target $9
ROTH
Buy
Zafgen initiated with a Buy at Roth Capital
Roth Capital analyst Sa'ar Yaniv started Zafgen with a Buy rating and $9 price target as he expects a number of events over the coming 12 months to drive investor interest.
CNC Centene
$90.88

0.34 (0.38%)

06/06/17
MSCO
06/06/17
INITIATION
Target $86
MSCO
Overweight
Centene initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Zack Sopcak initiated Centene with an Overweight and a $86 price target. The analyst thinks the HealthNet acquisition provides diversification and entry planned expansion in Medicare Advantage could offset potential headwinds.
07/26/17
PIPR
07/26/17
NO CHANGE
Target $105
PIPR
Overweight
Piper says double down on Centene, ups target to $105
Piper Jaffray analyst Sarah James attributes yesterday's post-earnings pullback in shares of Centene to the macro backdrop and the company's spending bump that she believes fuels the bear concern that constant spending for growth pressures margins. The analyst "strongly" disagrees and believe this is when investors should double down on Centene shares. The company will see the greatest multiple expansion in the group and has the highest potential for earnings upside, James tells investors in a research note. She raised her price target for the shares to $105 from $85 and keeps an Overweight rating on the name.
07/11/17
BERN
07/11/17
NO CHANGE
BERN
Centene price target raised to $100 from $85 at Bernstein
Bernstein analyst Lance Wilkes raised his price target on Centene based on his belief that the managed Medicaid market will grow over the long-term, particularly in long-term care. He keeps an Outperform rating on the stock.
06/23/17
JEFF
06/23/17
NO CHANGE
JEFF
Jefferies says healthcare rally 'appropriate' after 'toothless' AHCA rewrite
Jefferies analyst David Windley said the rally yesterday in healthcare stocks was appropriate given the "anemic" rewrite of the AHCA healthcare bill by Senate Republicans. The key changes are removal of "pay-for" taxes, a somewhat longer runway for Exchange cost-sharing reduction subsidies, and delayed Medicaid transition to per capita caps, he tells investors. Windley called Cigna (CI) "probably the safest MCO in this noise", adding that Humana (HUM) would benefit most from the proposed removal of the health insurer fee. Other publicly traded healthcare insurers include Aetna (AET), Anthem (ANTM), Centene (CNC), Health Net (HNT), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
TEX Terex
$41.73

1.68 (4.19%)

06/15/17
06/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Hold from Buy at Canaccord with analyst Michael Graham citing valuation. Graham maintained his $1,000 price target on Alphabet shares. 2. Mattel (MAT) downgraded to Neutral from Buy at DA Davidson with analyst Linda Bolton saying near-term business fundamentals have deteriorated after the company cut its dividend by 61%. 3. Brinker (EAT) downgraded to Neutral from Overweight at JPMorgan with analyst John Ivankoe saying he expects higher spending and weak industry trends to offset any possible sales improvement. 4. Terex (TEX) downgraded to Neutral from Buy at Goldman Sachs with analyst Jerry Revinch citing valuation. 5. Splunk (SPLK) downgraded to Neutral from Outperform at Wedbush analyst Steve Koenig citing the emergence of "meaningful competition," the "complexity" of its transition to the cloud, and "somewhat messy fundamentals." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/03/17
WELS
08/03/17
NO CHANGE
WELS
Terex weakness likely to be 'temporary,' says Wells Fargo
After Terex delivered beat and raise results but its stock fell, Wells Fargo blames the stock decline on margin concerns. The firm says that the company is seeing "stable to improving end market demand," calls its new guidance "somewhat conservative," and predicts that the stock's decline will be "temporary." It remains upbeat on the company's longer term outlook, saying that the company"could experience significant earnings growth in 2018 from 2017" and keeps an Outperform rating on the stock. .
05/11/17
05/11/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Home Depot (HD) downgraded to Neutral from Overweight at Atlantic Equities with analyst Sam Hudson citing valuation and raised its price target to $168 from $164. 2. Marathon Oil (MRO) downgraded to Neutral from Buy at BofA/Merrill with analysts led by Doug Leggate saying oil markets are taking longer to re-balanced than previously expected and the commodity team lowered its mid year peak in Brent oil prices to $60 from $70. The analyst sees reduced tailwinds from oil prices and risk that growth guidance will be revised lower. Leggate also said lower oil prices reduces capital availability and reduces the pace of development and planned growth for Marathon. 3. Abercrombie & Fitch (ANF) downgraded to Sell from Hold at Wunderlich with analyst Eric Beder citing the recent rally on reports of buyout talks. 4. Terex (TEX) downgraded to Underperform on earnings risk at BofA/Merrill with analyst Ross Gilardi citing disappointing first quarter results for Aerials and Cranes, combined with crude weakness. The analyst does not see a sustained pickup in the Cranes segment and sees rising competition for Aerials that could pressure margins next year. He believes consensus earnings estimates for 2018 are at risk and a lot of improvements are reflected in valuation. 5. Paccar (PCAR) downgraded to Neutral from Buy at BofA/Merrill with analyst Ross Gilardi saying his thesis for order inflection catalysts have played out and said Class 8 order strength could reverse in the second half of 2017. The analyst does not see new truck pricing getting much better and sees lack of catalysts on the horizon to push shares higher. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/15/17
GSCO
06/15/17
DOWNGRADE
Target $37
GSCO
Neutral
Terex downgraded to Neutral from Buy at Goldman Sachs
Goldman analyst Jerry Revinch downgraded Terex to Hold citing valuation and maintained a $37 price target.
MU Micron
$34.29

0.85 (2.54%)

09/12/17
GSCO
09/12/17
UPGRADE
Target $40
GSCO
Buy
Micron upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Mark Delaney upgraded Micron Technology (MU) to Buy post today's close and raised his price target for the shares to $40 from $33. The chipmaker closed the trading day up 85c to $34.29. DRAM pricing could rise in Q4 and the cycle could remain tight in 2018, Delaney tells investors in a research note. He believes upside to consensus earnings estimates and the stock's "discount" multiple could drive 20% share appreciation. Delaney after the close also downgraded ON Semiconductor (ON) to Neutral.
09/12/17
JPMS
09/12/17
NO CHANGE
JPMS
JPMorgan lays out iPhone content winners and losers into launch event
JPMorgan analyst Harlan Sur believes Apple's (AAPL) launch event today will be positive for Broadcom (AVGO) and Qorvo (QRVO) as well as Micron (MU) and Intel (INTC). The analyst sees content gains by Broadcom in wireless charging, touch controller, Wi-Fi/Bluetooth and GPS connectivity, and by Qorvo in low band power amplifier duplexers share and antenna tuning. Other companies with significant Apple exposure that would benefit from increased unit sales and/or modest content gains include Intel, Skyworks (SWKS), Knowles (KN), Micron, Cypress Semiconductor (CY), NXP Semiconductors (NXPI) and Texas Instruments (TXN), Sur tells investors in a research note. The analyst sees Analog Devices' (ADI) blended content at Apple declining as he believes the company will not be the touch controller for the OLED-version of the iPhone.
09/12/17
SBSH
09/12/17
NO CHANGE
Target $45
SBSH
Buy
Citi still sees upside to Micron's August quarter guidance
PC data points remain strong as August Taiwan notebook shipments were in-line with expectations while DRAM contract prices increased sequentially, Citi analyst Christopher Danely tells investors in a research note. The analyst continues to expect upside to Micron's August quarter guidance. He reiterates a Buy rating and $45 price target on Micron.
09/11/17
09/11/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: DowDuPont (DWDP) initiated with a Buy at BofA/Merrill and an Underweight at Barclays. 2. Brookfield Infrastructure (BIP) initiated with an Outperform at BMO Capital. 3. Micron (MU) initiated with an Outperform at FBN Securities. 4. TechnipFMC (FTI) initiated with a Hold at HSBC. 5. Thor Industries (THO) initiated with a Hold at Aegis. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
AMRK A-Mark Precious Metals
$18.82

0.79 (4.38%)

03/17/17
RILY
03/17/17
INITIATION
Target $18.75
RILY
Neutral
A-Mark Precious Metals resumed with a Neutral at B. Riley
B. Riley analyst Ian Corydon resumed coverage of A-Mark Precious Metals with a Neutral rating and $18.75 price target.
RLGT Radiant Logistics
$5.45

0.25 (4.81%)

WLL Whiting Petroleum
$4.44

0.33 (8.03%)

07/19/17
BOFA
07/19/17
INITIATION
Target $6
BOFA
Underperform
Whiting Petroleum reinstated with an Underperform at BofA/Merrill
BofA/Merrill analyst Asit Sen reinstated Whiting Petroleum with an Underperform and a $6 price target.
09/12/17
MSCO
09/12/17
DOWNGRADE
MSCO
Underweight
Whiting Petroleum downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Drew Venker downgraded Whiting Petroleum to Underweight from Equal Weight and reduced his price target to $3.50 from $5, citing weak risk-reward relative to peers.
09/05/17
TUDR
09/05/17
DOWNGRADE
TUDR
Sell
Whiting Petroleum downgraded to Sell from Hold at Tudor Pickering
06/21/17
GHSC
06/21/17
DOWNGRADE
Target $4
GHSC
Sell
Whiting Petroleum downgraded to Sell from Neutral at Seaport Global
Seaport Global analyst Mike Kelly downgraded Whiting Petroleum to Sell from Neutral and slashed its price target to $4 from $10 to reflect a new commodity price deck. Seaport Global's Energy team reduced its long-term oil forecast to $40/bbl from $50/bbl to reflect "relentless" US production growth. The firm sees the potential for the oil market to be "significantly over supplied in 2018 and cut its oil price forecast for first half 2017 to $45/bbl from $55/bbl and first half 2018 to $35/bbl from $55/bbl.
CLDX Celldex
$2.66

-0.03 (-1.12%)

08/01/17
08/01/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hain Celestial (HAIN) initiated with a Hold at Loop Capital. 2. Centennial Resource Development (CDEV) initiated with an Overweight at JPMorgan. 3. Neos Therapeutics (NEOS) initiated with an Overweight at Cantor. 4. Celldex (CLDX) assumed with a Buy at H.C. Wainwright. 5. SilverBow Resorces (SBOW) initiated with a Neutral at Seaport Global. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/10/16
BMUR
10/10/16
NO CHANGE
Target $16
BMUR
Buy
Celldex melanoma data encouraging, says Brean Capital
Brean Capital analyst Jason Wittes noted Celldex released Phase ll melanoma data. Although the data was not enough for an accelerated approval pathway, it still was encouraging, said Wittes, who noted the company said they would continue to explore the drug. Wittes maintained his Buy rating and $16 price target on Celldex shares.
11/07/16
AGIS
11/07/16
INITIATION
Target $10
AGIS
Buy
Celldex initiated with a Buy at Aegis
Aegis analyst Jason Wittes initiated Celldex with Buy and a $10 price target.
08/01/17
HCWC
08/01/17
INITIATION
Target $10
HCWC
Buy
Celldex assumed with a Buy at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis assumed coverage of Celldex Therapeutics with a Buy rating and $10 price target. The analyst expects an "important turnaround" over the next 12-months driven by the company's two lead assets, glembatumumab vedotin and varlilumab.
AGNC AGNC Investment
$21.50

-0.01 (-0.05%)

05/05/17
WELS
05/05/17
UPGRADE
WELS
Outperform
MTGE Investment Corp. upgraded on ROE improvement, valuation at Wells Fargo
As noted earlier, Wells Fargo upgraded MTGE to Outperform from Market Perform. As reasons for the upgrade, the firm cited the strong return on equity of the company's healthcare and agency units, valuation, and AGNC Investment's (AGNC) recent authorization to purchase its shares. Target to $18.50-$20.50 from $16-$17.
04/11/17
WELS
04/11/17
DOWNGRADE
WELS
Market Perform
AGNC Investment downgraded at Wells Fargo
As noted earlier, Wells Fargo downgraded AGNC to Market Perform from Outperform. The firm downgraded the stock based on valuation and the increased probability of the Fed lowering its balance sheet this year.
04/11/17
WELS
04/11/17
DOWNGRADE
WELS
Market Perform
AGNC Investment downgraded to Market Perform from Outperform at Wells Fargo
04/11/17
04/11/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wix.com (WIX) downgraded to Neutral from Overweight at Cantor with analyst Naved Khan citing limited upside potential with the stock up 70% year-to-date. The analyst believes the company's underlying fundamentals remain strong, however. He raised his price target for the shares to $80 from $65. 2. Sunoco (SUN) downgraded to Neutral from Buy at UBS with analyst Shneur Gershuni citing uncertainties around the company's new strategic direction following its asset sale announcement. 3. AGNC Investment (AGNC), CYS Investments (CYS), and Two Harbors (TWO) were downgraded to Market Perform from Outperform at Wells Fargo. 4. ABB (ABB) downgraded to Sell from Neutral at UBS. 5. OncoMed (OMED) downgraded to Market Perform from Outperform at BMO Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ON ON Semiconductor
$16.99

-0.13 (-0.76%)

09/12/17
GSCO
09/12/17
DOWNGRADE
GSCO
Neutral
ON Semiconductor downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Mark Delaney downgraded ON Semiconductor to Neutral citing the stock's relative outperformance and lack of catalysts over the next year. The shares are now trading within 5% of the analyst's unchanged price target of $18.
08/07/17
08/07/17
UPGRADE

Strong Buy
Follow-up: ON Semiconductor upgraded to Strong Buy at Needham
As previously reported, Needham upgraded ON Semiconductor to Strong Buy from Buy and raised its price target to $25 from $20. Analyst Rajvindra Gill said ON Semiconductor reported a strong quarter with demand across all segments and solid guidance. The analyst said the company is executing on its Fairchild integration, seeing strong wins within Auto and Industrial end markets, and closing lower margin businesses. Further, Gill expects On to begin to de-lever rapidly, utilizing the majority of its free cash flow to pay down debt and drive earnings.
08/07/17
NEED
08/07/17
UPGRADE
NEED
Strong Buy
ON Semiconductor upgraded to Strong Buy from Buy at Needham

TODAY'S FREE FLY STORIES

16:40
09/22/17
09/22
16:40
09/22/17
16:40
General news
Moody's downgrades UK's rating to Aa2, changes outlook to stable »

Moody's Investors…

A

Agilent

$65.78

-0.14 (-0.21%)

, MRK

Merck

$65.13

-0.47 (-0.72%)

16:36
09/22/17
09/22
16:36
09/22/17
16:36
Hot Stocks
Agilent receives expanded FDA approval for the use of Dako PD-L1 IHC 22C3 »

Agilent Technologies…

A

Agilent

$65.78

-0.14 (-0.21%)

MRK

Merck

$65.13

-0.47 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 08

    Nov

  • 30

    Nov

TYHT

Shineco

$3.23

-0.45 (-12.23%)

16:35
09/22/17
09/22
16:35
09/22/17
16:35
Hot Stocks
Shineco enters into strategic cooperation to establish Apocynum Industrial Park »

Shineco announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCI

Appliance Recycling

$1.16

0.03 (2.65%)

16:34
09/22/17
09/22
16:34
09/22/17
16:34
Hot Stocks
Appliance Recycling gets written notice of default »

On September 20,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNVA

Rennova Health

$0.22

0.0086 (4.07%)

16:31
09/22/17
09/22
16:31
09/22/17
16:31
Hot Stocks
Rennova Health announces 1 for 15 reverse stock split »

Rennova Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCI

Appliance Recycling

$1.16

0.03 (2.65%)

16:31
09/22/17
09/22
16:31
09/22/17
16:31
Hot Stocks
Breaking Hot Stocks news story on Appliance Recycling »

Appliance Recycling gets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
09/22/17
09/22
16:30
09/22/17
16:30
Options
Preliminary option volume of 13.9M today »

Preliminary option volume…

EKSO

Ekso Bionics

$1.28

0.14 (12.28%)

16:23
09/22/17
09/22
16:23
09/22/17
16:23
Hot Stocks
Ekso Bionics awarded government contract »

The Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

, AET

Aetna

$153.57

0.18 (0.12%)

16:22
09/22/17
09/22
16:22
09/22/17
16:22
General news
On The Fly: Top stock stories for Friday »

The major averages…

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CI

Cigna

$182.74

0.61 (0.33%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

FSLR

First Solar

$51.41

2.65 (5.43%)

FINL

Finish Line

$9.73

0.51 (5.53%)

ASND

Ascendis Pharma

$34.24

6.5 (23.43%)

VSAR

Versartis

$2.68

-18.925 (-87.62%)

ICPT

Intercept

$61.59

-12.11 (-16.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Oct

DLR

Digital Realty

$114.51

-1.72 (-1.48%)

16:19
09/22/17
09/22
16:19
09/22/17
16:19
Syndicate
Breaking Syndicate news story on Digital Realty »

Digital Realty files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

16:17
09/22/17
09/22
16:17
09/22/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSS

TSYS

$69.09

0.28 (0.41%)

16:16
09/22/17
09/22
16:16
09/22/17
16:16
Hot Stocks
TSYS announces resignation of COO Pamela Joseph »

TSYS announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
09/22/17
09/22
16:16
09/22/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$170.54

-0.57 (-0.33%)

16:15
09/22/17
09/22
16:15
09/22/17
16:15
Hot Stocks
Facebook's Zuckerberg plans to sell up to 75M shares to fund charity initiatives »

On September 22 Mr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

IDA

IDACORP

$87.79

-0.73 (-0.82%)

16:13
09/22/17
09/22
16:13
09/22/17
16:13
Hot Stocks
IDACORP raises quarterly dividend 7.3% to 59c per share »

The dividend declaration,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLRX

Valeritas

$3.06

-0.23 (-6.99%)

16:13
09/22/17
09/22
16:13
09/22/17
16:13
Syndicate
Valeritas announces common stock purchase agreement by Aspire Capital »

Valeritas Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$170.54

-0.57 (-0.33%)

16:12
09/22/17
09/22
16:12
09/22/17
16:12
Hot Stocks
Facebook dumps plan for new class of shares »

On September 21 the board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

DCIX

Diana Containerships

$0.42

-0.0373 (-8.16%)

16:11
09/22/17
09/22
16:11
09/22/17
16:11
Hot Stocks
Diana Containerships announces one-for-three reverse stock split »

Diana Containerships…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEP

Spectra Energy Partners

$43.89

0.34 (0.78%)

16:10
09/22/17
09/22
16:10
09/22/17
16:10
Syndicate
Breaking Syndicate news story on Spectra Energy Partners »

Spectra Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEV

Sevcon

$22.04

0.04 (0.18%)

, BWA

BorgWarner

$50.00

0.41 (0.83%)

16:10
09/22/17
09/22
16:10
09/22/17
16:10
Hot Stocks
Sevcon stockholders approve acquisition by BorgWarner »

Sevcon (SEV) announced…

SEV

Sevcon

$22.04

0.04 (0.18%)

BWA

BorgWarner

$50.00

0.41 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Oct

ATOS

Atossa Genetics

$0.49

-0.0296 (-5.71%)

16:07
09/22/17
09/22
16:07
09/22/17
16:07
Syndicate
Breaking Syndicate news story on Atossa Genetics  »

Atossa Genetics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CB

Chubb

$142.68

-0.27 (-0.19%)

16:06
09/22/17
09/22
16:06
09/22/17
16:06
Hot Stocks
Chubb CEO issues statement on EU-U.S. covered agreement »

Evan Greenberg, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 31

    Jan

AAPL

Apple

$153.39

-2.68 (-1.72%)

15:40
09/22/17
09/22
15:40
09/22/17
15:40
Options
Active trading in Apple as iPhone 8 makes a debut »

Active trading in Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

MRK

Merck

15:39
09/22/17
09/22
15:39
09/22/17
15:39
Hot Stocks
Merck gets FDA approval for Keytruda »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 08

    Nov

  • 30

    Nov

TAL

TAL Education

$33.09

-0.45 (-1.34%)

15:35
09/22/17
09/22
15:35
09/22/17
15:35
Options
Tal Education Group put volume heavy and directionally bearish »

Bearish flow noted in Tal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.